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Over the past decades the worldwide human life 
expectancy has increased substantially [1]. This, 
combined with several other factors, led to a dramatic 
and ongoing increase in the proportion of the world’s 
human population aged over 60 years [2]. As a 
consequence, the number of people experiencing age-
related deterioration in health is rising, which will cause 
a great burden on the healthcare system [2]. The 
deterioration of the physiological integrity leads to an 
increased incidence of major human pathologies and 
increases the probability of death [1, 3]. Age remains 
the main risk factor for the development of debilitating 
and life-threatening, age-related pathologies such as 
cardiovascular disease, cancer, type 2 diabetes mellitus 
and neurodegenerative disorders including dementia [1-
4]. Understanding what causes aging and how aging and 
age-related diseases are interrelated is therefore 
essential. This led to an increased interest in aging 
research and made healthy aging a hot  topic in research. 
 
 
































Research on the aging process of sometimes distantly 
related model organisms – including yeast, nematodes, 
flies, mice and humans – led to the idea that lifespan 
regulation and aging are modulated by common and 
conserved mechanisms in many, if not all species [3, 5]. 
The discovery that exogenous hydrogen sulfide (H2S) 
prolongs the lifespan of the nematode Caenorhabditis 
elegans [6] has led to new insights in its role in health 
and disease, suggesting a relationship between H2S and 
aging [7]. This gaseous molecule was not considered to 
be physiologically relevant until the 1990s. Since then, 
increasing evidence showed its beneficial effects in 
several disease models, including age-related 
pathologies [8]. The age-dependent decline in plasma 
H2S levels found in human subjects 50 to 80 years of 
age supports the link between H2S and aging [9]. 
However, the precise relationship between H2S and 
aging is still largely unknown as both the role of H2S in 
the aging process as well as the effects of aging on the 
metabolism of H2S are not fully understood yet [8, 10]. 
This review outlines the current knowledge on the 

















leading to death. Research on aging  largely focuses on the  identification of mechanisms  involved  in the aging
process. Several proposed aging theories were recently combined as the ‘hallmarks of aging’. These hallmarks
describe  (patho‐)physiological  processes  that  together,  when  disrupted,  determine  the  aging  phenotype.
Sustaining evidence shows a potential role for hydrogen sulfide (H2S) in the regulation of aging. 
Nowadays,  H2S  is  acknowledged  as  an  endogenously  produced  signaling  molecule  with  various  (patho‐)
physiological effects. H2S is involved in several diseases including pathologies related to aging. In this review, the
known,  assumed  and  hypothetical  effects  of  hydrogen  sulfide  on  the  aging  process  will  be  discussed  by
reviewing its actions on the hallmarks of aging and on several age‐related pathologies. 
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relationship between hydrogen sulfide and aging so as 
to determine the potential beneficial effects of hydrogen 
sulfide in aging and age-related pathologies. 
 
THE AGING PROCESS 
 
Aging is the progressive loss of physiological function 
which emerges when organisms grow older, with death 
of the organism as the ultimate, inevitable consequence 
[1, 3, 11]. Classic symptoms of human aging include 
graying and loss of hair, loss of hearing and eyesight, 
reduced fertility, immune system failure and loss of 
cognition [2]. These classical symptoms decrease the 
quality of life of most elderly, but are generally 
accepted as inevitable consequences of aging. These 
symptoms are believed to result from time-dependent 
accumulations of cellular damage leading to a gradual 
loss of function at the molecular, cellular, tissue and 
organismal level [12, 13]. A variety of molecular, 
biochemical and metabolic alterations occurring at the 
cellular level are thought to cause these functional 
losses [2]. For many years, aging research was largely 
focused on identifying the underlying cellular 
mechanisms as to find novel drug targets to modulate 
the aging process and to attain healthy aging by 
delaying the onset of age-related pathologies [3]. This 
approach has led to some unsubstantiated and opposing 
claims for potential cures as opposed to disease-oriented 
research [14]. It turned out that the aging processes are 
highly complex with numerous mechanisms and 
pathways involved. Several theories and mechanisms 
























These theories are not mutually exclusive and attempts 
to unify them into one theory have not yet succeeded. 
Therefore, the molecular and cellular pathways 
generally considered to contribute to the process of 
aging were categorized and proposed as the ‘hallmarks 
of aging’ [15]. 
 
Hallmarks of aging 
 
In total, nine hallmarks of aging were proposed which 
together are thought to determine the aging phenotype 
(Figure 1) [15]. The criteria for the hallmarks are that 
each hallmark should be manifested during normal 
aging and that its experimental intervention should both 
accelerate or retard the normal aging process, depending 
on the intervention [15]. However, not all hallmarks 
currently meet up to all the criteria as amelioration of 
the aging process is not always successful [15]. The 
hallmarks are interconnected, making it difficult to 
determine the relative contribution of each hallmark to 
aging. There is some degree of hierarchy between the 
hallmarks of aging and therefore they are divided into 
three categories: primary, antagonistic and integrative 
hallmarks [15]. Primary hallmarks, including genomic 
instability, telomere attrition, epigenetic alterations and 
loss of proteostasis, are considered to be the primary 
cause of damage at cellular level which progressively 
accumulates with time. In response, antagonistic 
hallmarks that are principally beneficial and mitigate 
damage may become deleterious themselves, 
progressively contributing to aging. Deregulated 
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senescence belong to this category. Finally, the 
integrative hallmarks arise when the tissue homeostatic 
mechanisms cannot compensate for the damage caused 
by the previous two categories. The integrative hall-
marks, stem cell exhaustion and altered intercellular 
communication, are ultimately responsible for the age-
related functional declines [15]. All nine hallmarks of 
aging and the effects of H2S on each hallmark will be 




As research on aging is as old as the hills, it has 
witnessed the emergence of several new fields of 
research. Among them is the investigation on 
gasotransmitters: small, labile and endogenously-
generated gaseous transmitters that mediate physiology 
and disease. Nitric oxide (NO) and carbon monoxide 
(CO) were the first two identified gasotransmitters and 
based on their biology several criteria to classify 
gasotransmitters were proposed [16]. Gasotransmitters 
diffuse freely across membranes and have well-defined 
functions in signal transduction, acting on specific 
cellular and molecular targets at physiologically 
relevant concentrations. Their endogenous production is 
regulated by specific substrates and enzymes in 
mammalian cells and their function can be mimicked by 
exogenously applied counterparts or obtained from the 
diet [16]. 
 
Nowadays, hydrogen sulfide (H2S) is acknowledged as 
the third gasotransmitter [8, 16]. The biological and 
medical importance of the gasotransmitters NO, CO and 
H2S is now widely recognized. Whereas the endogenous 
concentrations of each gasotransmitter in the circulation 
or in tissues are relatively low, these concentrations are 
sufficient to execute their specific physiological actions 
[17-19]. Recently, other small gaseous molecules were 
evaluated for their candidacies as gasotransmitter and as 
ammonia (NH3) did meet all criteria for 
gasotransmitters it should be classified as the fourth 
gasotransmitter [17]. Over the past decade, evidence 
demonstrating the importance of gasotransmitters to the 
human body mounted as their regulatory capacities in 
controlling important physiological functions, like 
vascular tone, defense against pathogens, neuro-
modulation, apoptosis and energy metabolism, were 
shown [20].  
 
Despite the fact that all gasotransmitters have their own 
specific functions and targets, it is plausible that 
interactions take place between their signaling roles 
[21]. Indeed, gasotransmitters share several targets and 
functions with one another [16, 20]. The activities of 
these shared targets are, however, modulated through 
different mechanisms [8, 22, 23]. Another possibility is 
that the eventual outcome of the actions of 
gasotransmitters is the same despite the fact that 
different targets and mechanisms were involved [17]. 
Studies also revealed crosstalk between gaso-
transmitters [22-24] in such a way that “each gas may 
antagonize, reciprocally regulate or potentiate the 
cellular effects of each other through their production, 
downstream molecular targets and direct chemical 
interactions” [21]. Their interconnectedness complicates 
the search for the specific effects of each individual 
gasotransmitter, as observed beneficial effects after the 
modulation of one gasotransmitter might be the result of 




Historically, hydrogen sulfide was known as a toxic gas 
characterized by the strong odor of rotten eggs. Until 
the 1990s, the research on H2S was mainly focused on 
its toxicity. Accidents in industrial settings showed the 
danger of the gas, as exposure to high concentrations of 
H2S caused collapse, unconsciousness and respiratory 
paralysis, and ultimately led to death [25]. Since then, 
new knowledge has positively transformed the way H2S 
is perceived, as studies discovered physiological 
functions of H2S in biological systems [26, 27] and 
showed endogenous production of H2S in many parts of 
the mammalian body [8, 28]. As H2S is soluble in both 
water and lipids, it easily penetrates biological 
membranes without facilitation of membrane channels 
[29]. The term ‘H2S’ in this review refers to H2S and its 
anions, as more than 80% of this weak acid dissociates 
to hydrosulfide anion (HS-) and proton (H+) at the 
physiological pH (pH=7.4) in the circulation and the 
cells [30]. The contribution of the other sulfide anion 
(S2-) is negligible at physiological conditions, as the 
dissociation of HS- to S2- occurs almost exclusively at 
high pH [29, 30]. It is not possible to separate the 
effects of H2S and HS- on physiological functions and 
signaling processes since these species coexist at 
physiological conditions in cells and in circulation [29, 
31, 32]. 
 
Endogenous and exogenous sources of H2S  
 
Endogenous production 
Hydrogen sulfide is endogenously produced by most 
mammalian cells via enzymatic and non-enzymatic 
pathways [8, 28]. However, the contribution of the non-
enzymatic pathway, in which elemental sulfur or 
organic polysulfides are reduced to H2S, is small [16, 
33, 34]. Stressful conditions, like increased oxidative 
stress and hyperglycemia, promote H2S production from 
this pathway [8].  
  
www.aging‐us.com                    2266                                                      AGING (Albany NY) 
The enzymatic production of H2S depends on three 
enzymes, namely cystathionine γ-lyase (CSE), 
cystathionine β-synthase (CBS) and 3-mercapto-
pyruvate sulfurtransferase (3MST) (Figure 2) [35, 36]. 
The vitamin B6-dependent enzymes CBS and CSE are 
normally localized in the cytoplasm and translocate to 
mitochondria under stressful conditions to promote the 
mitochondrial production of H2S and adenosine 
triphosphate (ATP) [37-39]. The other H2S producing 
enzyme 3MST is mainly localized in mitochondria and 
is found in the cytoplasm to a minor extent [40, 41]. 
 
Sulfur-containing amino acids, like methionine and 
cysteine, are the main precursors for the enzymatic 
generation of H2S. CBS and CSE account for the 
majority of the endogenous produced H2S in 


































specific and was identified in liver, kidney and brain 
cells, skin fibroblasts and blood lymphocytes among 
others [16].  
 
After the conversion of methionine to homocysteine, 
CBS is required to form cystathionine from 
homocysteine whereupon CSE converts cystathionine to 
L-cysteine, the latter being the key substrate in the 
generation of H2S. Hydrogen sulfide can also be 
generated directly from homocysteine by CSE, but not 
by CBS [42]. L-cysteine is used by CBS and CSE to 
form H2S and by cysteine aminotransferase (CAT) to 
produce 3-mercaptopyruvate, the main substrate for H2S 
production by 3MST. In the presence of D-amino acid 
oxidase (DAO), 3-mercaptopyruvate can also be 
produced from D-cysteine in peroxisomes [43]. The 



































The  endogenous production of H2S  in mammalian  cells.  Several  important  enzymes  are mentioned  along  the  arrows.
Right  panel:  The  exogenous  production  of  H2S  in  the  gastrointestinal  tract  by  the  intestinal microbiota  and  sulfate‐
reducing bacteria,  for which  the H2S production  is endogenous. The dashed  lines between  the  left and  the  right panel
indicate the transport of molecules between the compartments.  
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release H2S [44]. In vivo, H2S is metabolized by 
methylation in the cytosol [16] or by oxidation in 
mitochondria, whereupon it is secreted as sulfite, 
thiosulfate and sulfate [36]. In vivo, hydrogen sulfide 
can be re-formed from sulfite and thiosulfate, but not 
sulfate [39, 45]. 
 
Exogenous production 
Aside from endogenous H2S production, H2S can be 
produced by bacteria in the mouth and the 
gastrointestinal tract (Figure 2). From the perspective of 
the host-organism, this H2S production is exogenous as 
it is produced by bacteria in the external milieu of the 
host and not by that organism itself. Sulfur-reducing 
bacteria, for example, are part of the normal intestinal 
microbiota in healthy individuals and have been 
identified in human feces [46]. Hydrogen sulfide is 
synthesized by these bacteria from alimentary as a 
consequence of their metabolic activity in which they 
use sulfate as a terminal electron acceptor [8, 47]. The 
main source of this inorganic sulfate is the aliment, 
however the secretion of sulfate by the host 
gastrointestinal tract may also be an important source 
[48]. As the intestine is highly permeable to H2S [49], 
the production of high concentrations of H2S by these 
bacteria would be expected to cause severe tissue 
damage [50]. The exogenous production of H2S was 
also suggested to play a role in several pathologies of 
the intestinal tract, like inflammatory bowel disease and 
colorectal cancer, but direct links are yet to be 
established [51-53]. The intestinal mucosa is thought to 
protect the gastrointestinal tract against high 
concentrations of H2S by a specialized detoxification 
system which rapidly and effectively metabolizes H2S 
to thiosulfate and sulfate [8, 50], whereupon sulfate can 
be secreted [48]. It is possible that defects in this 
detoxification pathway play a part in intestinal 
pathologies [49, 50]. The importance of proper H2S 
catabolism is demonstrated in patients with ethyl-
malonic encephalopathy, a disease in which 
malfunction of the persulfide dioxygenase ETHE1 
results in multi-organ pathology in the brain, 
gastrointestinal tract and peripheral vessels for example 
[54]. Due to mutations in the ETHE1 gene [55], the 
inorganic sulfur catabolism is impaired which leads to 
the accumulation of H2S and various H2S-related toxic 
effects in different tissues [54, 56, 57]. Decreased 
exogenous H2S production, due to treatment with the 
antibiotic metronidazole, and improved H2S buffering, 
by administration of the glutathione precursor N-
acetylcysteine, caused marked clinical improvements in 
patients with ethylmalonic encephalopathy [58]. The 
exact role of exogenously produced H2S in (patho-) 
physiology still needs to be determined and separated 
from the effects of endogenously produced H2S [53]. 
Exogenous administration 
 
In experimental settings, levels of H2S can be 
manipulated by the administration of exogenous H2S or 
H2S releasing compounds. Sulfide-sodium salts, exposure 
to gaseous H2S, slow-releasing H2S donors, hybrids of 
H2S-donors and known substances, thiosulfate, cysteine 
analogs and modulation of the expression or activity of 
H2S producing enzymes are several options for altering 
H2S levels in experimental settings.  
 
HYDROGEN SULFIDE AND (PATHO-) 
PHYSIOLOGY 
 
Nowadays, H2S is recognized as an important signaling 
molecule with various (patho-)physiological effects and 
was shown to be involved in cardiovascular system 
diseases, cancer and neurodegenerative diseases [8, 10]. 
The most widely studied functions of endogenous H2S 
relate to its vasodilatory effects [23, 59, 60] and its 
ability to reduce and modulate oxidative stress. 
Additionally, several other physiological function of 
H2S signaling were proposed [10]. These studies 
demonstrated that H2S has the potential to provide 
beneficial effects on health in many (patho-)physio-
logical processes and age-related pathologies. However, 
the effects of H2S on aging are not that commonly 
studied. Nevertheless, pathways of most – if not all – 
hallmarks of aging are found to be influenced by H2S. 
Studies that identified the effects of H2S on these 
pathways are thus relevant in the light of aging and are 
described next. 
 
HYDROGEN SULFIDE AND AGING 
 
Role of H2S in the primary hallmarks of aging 
 
Genomic instability 
Exogenous and endogenous treats continuously 
challenge genome integrity and stability [61]. 
Organisms have evolved a complex network of repair, 
damage tolerance and checkpoint mechanisms to 
counteract most damage caused to the nuclear genome 
[15, 61, 62]. Artificial reinforcements in these 
mechanisms extended healthy lifespan in mice [63] and 
were suggested to delay aging [15]. In contrast to the 
nuclear genome, the protection of mitochondrial DNA 
is not that efficient [64] and is heavily dependent on the 
machinery of nuclear DNA repair [65]. Besides that, 
mitochondrial DNA is more vulnerable to mutations 
due to the oxidative microenvironment of the 
mitochondria and the lack of protective histones on 
mitochondrial DNA [64]. Therefore, aging-associated 
mutations and deletions in the mitochondrial genome 
may also contribute to the aging process [66]. 
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Besides the destabilizing effects of alterations in the 
nuclear and mitochondrial genome, the stability of the 
genome can also be deteriorated by defects in the 
nuclear architecture [67]. Alterations in the nuclear 
lamina have been detected in disease and during normal 
aging [68, 69], causing changes in several stress 
pathways [70, 71] and attrition of adult stem cells [72, 
73]. The lifespan of progeroid mice was extended after 
these pathways were restored [71, 74], indicating their 
importance in the aging process.  
 
Effect of H2S on genome stability 
Genomic stability can be affected by H2S, but the data 
are conflicting. In Chinese hamster ovaries, human 
colonic epithelial cells and human lung fibroblasts, H2S 
may exert genotoxic actions [75, 76]. Human fibroblasts 
treated with NaHS showed a concentration-dependent 
increase in the formation of micronuclei, indicating 
DNA damage, and were propelled towards cell-cycle 
arrest and apoptotic death through DNA damage 
responses involving p53, p21 and the apoptosis 
regulators, Bax and cytochrome c [76]. H2S was 
genotoxic at concentrations of 0.25 mmol/L, which is 
similar to the physiological concentration observed in 
mouse colon (0.2–1 mmol/L [77]) and human feces 
(0.2–3.4 mmol/L H2S [78]) [75]. However, the 
genotoxic concentration is much higher than the human 
plasma concentration of H2S (10–100 μmol/L) [79, 80]. 
High, genotoxic H2S concentration in the gut, possibly 
due to production by commensal sulfate-reducing 
bacteria, may play a role in the genomic instability and 
the acquisition of mutations observed in colorectal 
cancer [75]. However, it must be noted that the reliable 
measurement of H2S is still a topic of discussion, so it is 
not known whether these mentioned plasma 
concentrations are accurate or comparable between 
studies [32, 81-85]. 
 
Others point out the positive effects of H2S on genome 
stability. Hydrogen sulfide attenuates DNA damage in 
human endothelial cells and fibroblasts by increasing 
MEK1 S-sulfhydration, ERK1/2 and PARP-1 activity 
leading to the activation of DNA damage repair 
mechanisms and protection from cellular senescence 
[86]. The CSE/H2S pathway is important in genome 
stability and cell proliferation, as its inhibition in 
hepatoma cells decreased their proliferation, enhanced 
ROS production and mitochondrial disruption, 
pronounced DNA damage and increased apoptosis [87]. 
Proliferation was decreased due to downregulation of 
ERK1/2 activity [87]. The increased apoptosis after H2S 
signal inhibition was associated with the activation of 
p53, p21, Bax and other pro-apoptotic factors [87]. 
Thus, both high [76] as well as low H2S levels [87] can 
induce apoptosis. Two other studies showed protective 
effects of H2S containing water [88] and a 
mitochondrially-targeted H2S donor (AP39) [89] against 
oxidative stress and oxidative DNA damage in 
peripheral blood mononuclear cells of Alzheimer’s 
patients and a murine brain microvascular endothelial 
cell line, respectively, again showing the positive 
effects of increased intracellular H2S on nuclear and 
mitochondrial genome stability. These and other studies 
also described improved cell viability [88, 90] and 




The genomic stability systems also include specific 
mechanisms for maintaining the appropriate length and 
functionality of telomeres [91]. Telomere maintenance 
is, however, considered as a distinct hallmark of aging. 
The unique DNA-protein structure of telomeres is 
essential for maintaining genomic integrity, as they cap 
the terminal ends of linear chromosomes in order to 
prevent appearing as DNA double-strand breaks in need 
of repair and to protect these ends from degradation 
[92]. Normal aging in mammals is accompanied by the 
progressive and cumulative loss of telomere length and 
function as a consequence of normal replication, due to 
oxidative damage or as a result of replication errors [15, 
92, 93]. Telomerase, a specialized DNA polymerase, is 
required to elongate telomeres as the replicative DNA 
polymerase lacks this capacity. However, most 
mammalian somatic cells do not express telomerase, 
making telomeres particularly susceptible to age-related 
deteriorations [91]. When telomeres become too short 
or when too much damage has occurred, they become 
dysfunctional. Dysfunctional telomeres are highly 
efficient in inducing apoptosis and/or cellular 
senescence and accelerate aging in mice and humans 
[15, 94, 95]. Experimental stimulation of telomerase 
was shown to delay or even reverse aging [15, 96].  
 
Effect of H2S on telomere maintenance 
No studies have specifically described the effect of H2S 
on telomere maintenance, but the described protective 
effects of physiological levels of H2S on genome 
stability might also preserve telomeres and prevent 
telomere attrition and dysfunction. 
 
Epigenetic alterations 
Along with the genetic components in aging, a role for 
non-genetic factors in the aging process is implicated 
[97].  Epigenetic alterations such as posttranslational 
modification of histones, alterations in DNA 
methylation patterns and chromatin remodeling [15, 97-
99], can regulate the accessibility of the DNA and 
underlie the differential gene transcription observed 
between cell types, developmental stages and disease 
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states [100-102]. Several histone modifications are 
associated with aging [103, 104], such as the 
deacetylase activity of sirtuins. Manipulation of a single 
sirtuin gene in several animal models resulted in 
noteworthy effects on longevity by slowing down 
organismal aging [105]. At least three members of the 
sirtuin family, namely SIRT1, SIRT3 and SIRT6, are 
involved in the regulation of longevity and/or healthy 
aging in mammals [15]. The underlying mechanisms by 
which they affect these processes differ between the 
sirtuins [15].  
 
Besides histone modification, DNA methylation also 
alters chromatin structure and regulates gene expression 
[106]. Alterations in DNA methylation are considered 
to be a central mechanism in normal development, some 
diseases and in the aging process [107] and accumulate 
during life, as was shown in a study in centenarians and 
newborns [108]. However, the relationship between 
DNA methylation and aging is complex, as both a 
global decrease in DNA methylation, as well as specific 
age-related hypermethylation at certain developmentally 
regulated genes, including various tumor suppressor 
genes and Polycomb target genes, were described in 
different human tissues during aging [15, 98, 108, 109]. 
Among the differentially methylated regions, some 
were shown to be related with age or were associated 
with age-related phenotypes [110]. Nevertheless, direct 
experimental evidence showing that organismal lifespan 
can be extended by altered DNA methylation patterns 
was not found thus far. 
 
Several other key chromosomal protein and chromatin 
remodeling factors are diminished in normal and 
pathological aged cells [111, 112]. Alterations in their 
expression altered the lifespan of flies [113], 
demonstrating their role in the aging process. 
 
Effect of H2S on epigenetics 
Several studies show epigenetic chromatin modulation 
by H2S [114, 115]. Slow-releasing H2S donors inhibit 
tumor growth both in vitro and in vivo by a combination 
of cell-cycle arrest and apoptosis promotion, which was 
related to histone hyperacetylation [116-118]. The 
transcription of pro-inflammatory cytokines, like IL-6 
and TNF-α, was altered due to histone modifications 
and accompanying changes in chromatin structure 
[114]. Expression and activity of SIRT1 is mediated by 
H2S [10, 119, 120]. The protective effects of H2S 
against senescence [119, 121], apoptosis [90] and 
neurotoxicity of formaldehyde [120] were found to be 
modulated through SIRT1 activity and were attenuated 
by SIRT1 inhibition [90, 120]. Direct anti-apoptosis and 
antioxidant effects of H2S via the SIRT1 pathway were 
demonstrated in cells under oxidative stress [90, 122].  
H2S is also associated with altered DNA methylation. 
High plasma levels of homocysteine inhibit the 
CSE/H2S signaling and trigger mitochondrial toxicity, 
endothelial dysfunction and inflammation by increasing 
DNA methylation and transcriptional alterations, like 
elevation of TNF-α and IL-1β plasma levels and 
inhibition of CSE expression [123, 124]. Supply of H2S-
releasing compounds rescued these cells from the 
harmful effects of high levels of circulatory 
homocysteine [123, 124]. Hydrogen sulfide alters the 
epigenetics of the mitochondrial genome, contributing 
to the replication of mitochondrial DNA, cellular energy 
metabolism and mitochondrial bioenergetics [125]. 
Exogenous H2S repressed the expression of DNA 
methyltransferase in cultured smooth muscle cells and 
aortic tissues from mice, resulting in the demethylation 
of certain regions of the mitochondrial genome, whereas 
CSE deficiencies showed opposite effects [125]. These 
studies demonstrate that epigenetics can be changed by 
alterations in the transsulfuration pathway. 
 
Loss of proteostasis 
Many studies demonstrated the importance of a proper 
protein homeostasis or ‘proteostasis’ in health and 
disease. Permanent or temporal alterations in 
proteostasis, as a result of changes in physiology or 
exposure to environmental stresses, are a common 
feature of development and cellular and organismal 
aging [126, 127]. Several age-related pathologies, like 
Alzheimer’s and Parkinson’s disease, are characterized 
by the appearance of misfolded or aggregated proteins 
with disease-causing, proteotoxic effects [128, 129]. In 
order to preserve the integrity, stability and 
functionality of the proteome, all cells take advantage of 
a network of quality control pathways that coordinate 
the synthesis, folding, disaggregation and degradation 
of proteins and their posttranslational modifications [15, 
127]. This proteostasis network includes the 
translational machinery, molecular chaperones, the 
ubiquitin-proteasome system and the lysosomal 
autophagy machinery [129]. Several signaling pathways 
were shown to assist and modify the proteostasis 
network but are not considered as direct components of 
that network [127]. Molecular chaperones, like proteins 
of the heat-shock family, mediate the folding and 
stabilization of correctly folded proteins [126, 130]. 
Studies showed the importance of chaperones in the 
regulation of lifespan in several model organisms [131-
133]. However, the efficacy of protein quality control 
by these chaperones declines with aging [134]. Affected 
proteins are normally targeted to destruction by the 
ubiquitin-proteasome or the lysosomal autophagic 
pathways [126, 135]. However, the activities of these 
proteolytic systems also decline with aging [136, 137]. 
Numerous studies showed that the induction of these 
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pathways extended longevity in several animal models 
[136, 138-141]. Together, these studies support the idea 
that collapsing proteostasis contributes to the aging 
process. 
 
Effect of H2S on proteostasis 
Hydrogen sulfide affects the maintenance of cellular 
protein homeostasis. NaHS treatment suppresses the 
increased protein synthesis and aggregation in cultured 
brain slices from Zucker diabetic rats, normalizing 
proteostasis and counteracting oxidative stress [142]. 
NaHS inhibited the formation of advanced glycation 
end products, which disrupt proteostasis, in human 
neuroblastoma SH-SY5Y cells exposed to D-galactose 
[143]. Exposure to H2S protected animals against 
hypoxia-induced disruptions of proteostasis, like protein 
aggregation and cytotoxicity, and reversed the 
detrimental effects of hypoxia on protein homeostasis 
[144]. Cardioprotective effects of heat-shock protein-90 
were observed in chemical hypoxia-induced injury to 
rat H9c2 cardiomyoblasts after NaHS exposure, 
inhibiting oxidative stress and preserving mitochondrial 
function [145]. These effects might be a result of 
improvement to cellular proteostasis. H2S may also 
affect proteins through S-sulfhydration, which is a form 
of posttranslational modification, leading to changes in 
intracellular signaling [146]. 
 
In the premature aging disorder Werner syndrome, 
fibroblasts are highly stressed with extensive protein 
production and aggregation in the cytosol accompanied 
by nuclear dysmorphia [147]. Treatment with NaHS or 
rapamycin normalized the morphological phenotype 
and restored proteostasis by blocking mTOR activity 
and annulling protein aggregations [147]. These studies 
demonstrate that H2S can influence the maintenance of 
cellular protein homeostasis. 
 
Role of H2S in the antagonistic hallmarks of aging 
 
Deregulated nutrient sensing 
 
Several nutrient signaling pathways have been linked to 
aging. Restricting the dietary caloric intake is the most 
effective intervention known to slow down aging and 
extend lifespan in many species [14, 148]. The 
insulin/IGF1 signaling pathway is the most conserved 
glucose sensing and the best-characterized aging-
controlling pathway [15]. Attenuations at different 
levels in this pathway were associated with lifespan 
extension in animals [149-152] and humans [153, 154]. 
Among the downstream modulators of the insulin/IGF-1 
network, the FOXO transcription factors are the most 
relevant [149], as they modulate the expression of pro-
longevity genes in the nucleus [155-157]. Their 
translocation to the cytosol, due to phosphorylation, 
inactivates these transcriptional targets [150]. 
Paradoxically, declines in the insulin/IGF-1 network 
were shown during both normal and premature aging 
[158]. 
 
The mTOR pathway is another major nutrient-sensing 
pathway with effects on aging [159]. Animal studies 
showed that genetic downregulation of mTOR or 
treatment with the mTOR inhibitor rapamycin extended 
longevity in yeast, worms, flies and mice [160, 161]. 
Rapamycin also improved and protected against age-
related pathologies in mouse models of Alzheimer's 
disease, Parkinson's disease and cardiomyopathy [162, 
163]. Along with these beneficial effects, several 
harming side-effects of mTOR inhibition, like impaired 
wound healing, insulin resistance and cataract, were 
shown in mice [161, 164]. 
 
AMP-activated kinase (AMPK) is a highly conserved 
nutrient and low-energy sensor [15, 165, 166]. Besides 
its functions in the maintenance of energy metabolism, 
it was suggested that AMPK coordinates a large 
signaling network of transcription factors [165, 167], 
including pathways involved in aging [166]. Several 
studies on model organisms demonstrated the crucial 
role of AMPK in the regulation of longevity in worms, 
flies and mice [166]. The responsiveness to AMPK 
signaling declines with age [168], contributing to many 
age-associated diseases [169]. 
 
The previously discussed sirtuins are part of the nutrient 
signaling pathway, as these NAD-dependent protein 
deacetylases respond to cellular low-energy states, 
cause epigenetic alterations and contribute to the aging 
process [15, 170]. 
 
Effect of H2S on nutrient sensing 
Contributions of H2S signaling to several nutrient 
sensing pathways are described. H2S impairs the 
insulin/IGF-1 signaling pathway as it inhibits insulin 
secretion by pancreatic beta-cells and insulin secreting 
cell lines by stimulating ATP-sensitive potassium 
channels [171-173]. Administration of NaHS to 
cardiomyocytes increased glucose uptake by these cells 
[174, 175], increased the phosphorylation of several 
components of the insulin/IGF-1 signal pathway, like 
insulin receptor, PI3K and Akt [175], and improved 
glucose metabolism [174, 176]. H2S regulated vaso-
relaxation in spontaneously hypertensive rats through 
the inhibition of FOXO1 and FOXO3 phosphorylation, 
which resulted in their nuclear translocation and their 
binding to target gene promotors [177]. H2S was also 
shown to function as an endogenous regulator of PTEN, 
the main antagonist of the PI3K-Akt axis in the 
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insulin/IGF-1 signal pathway, by modifying PTEN 
activity through S-sulfhydration [178, 179]. Following 
incubation with H2S, oral keratinocyte stem cells 
increased their PTEN expression [180]. These studies 
indicate a regulatory role for H2S in the insulin/IGF-1 
signaling network. 
 
Administration of L-cysteine or Na2S to human U937 
monocytes exposed to high-glucose, as a model for 
diabetes, increased cellular PIP3, AMPK phosphoryla-
tion and PPARγ expression [181]. CSE inhibition 
prevented the L-cysteine-induced increase in PIP3 
[181]. Various H2S-releasing compounds activated 
AMPK signaling, resulting in protective effects on 
cultured cells, tissues and whole organisms [182-186]. 
Interestingly, the well-established AMPK activator 
metformin, a widely prescribed insulin sensitizer and a 
first-line antidiabetic drug, increased H2S concentration 
in various tissues [187], indicating that H2S might 
mediate metformin’s effects. H2S was shown to 
promote AMPK signaling and inhibit mTOR complex 1 
activity in renal epithelial cells [188]. NaHS treatment 
blocked mTOR activity in Werner syndrome fibroblasts 
[147] and the human colon adenocarcinoma cell line 
HR-29 [189]. Contrary, NaHS treatment increased 
mTOR phosphorylation in reperfused hearts and 
concanavalin A-induced hepatitis [190, 191]. 
 
H2S also regulates the activity of the low-energy sensing 
sirtuins. Treatment with NaHS enhanced the SIRT1 
deacetylase activity in human umbilical vein endothelial 
cells [119, 121]. In addition, increases in the expression 
of SIRT1 [119, 120], SIRT3 [180, 192] and SIRT6 [180, 
193] were shown after treatment with H2S.  
 
Mitochondrial dysfunction 
Mitochondrial dysfunction and oxidative stress are 
thought to play an important role in aging by affecting 
intracellular signaling and interorganellar crosstalk 
[194-196]. Several age-related pathologies, like 
neurodegenerative diseases, diabetes, cancer, cellular 
senescence and impaired stem cell homeostasis were 
linked to ROS and dysfunctional mitochondria [197, 
198]. Mild mitochondrial toxins, like metformin and 
resveratrol, retarded aging by inducing a low-energy 
state with increased AMP levels and AMPK activation 
[199] and by mediating the master antioxidant regulator 
Nrf2 [200]. These studies indicate that mild mito-
chondrial stresses might be preventive against age-
associated pathologies. 
 
Mitochondria are the major producers of ROS, as its 
synthesis is an inevitable by-product of oxidative 
phosphorylation. The mitochondrial function declines 
with age, leading to increased electron leakage and ROS 
production and reduced ATP generation [196], which 
may, in turn, cause extra damage to the mitochondrial 
genome and further decline mitochondrial function. 
This vicious cycle, known as the mitochondrial free 
radical theory of aging [201], may lead to cellular 
energy depletion and ultimately to cell death [202, 203]. 
Since its proposal, numerous studies were performed to 
test the theory, generating inconsistent and conflicting 
results [204]. This led to a reconsideration of the role of 
ROS in aging [205]. In contrast to what was seen in 
severe mitochondrial stress, low physiological levels of 
intracellular ROS, maintained within a narrow range 
[206], have signaling functions in many cellular and 
systemic physiological processes [198, 207], inducing 
beneficial long-lasting metabolic and biochemical 
changes that may actually improve the cellular fitness 
[15, 197, 208, 209]. The phenomenon in which the 
exposure to low levels of a stressor induces 
compensatory biological processes, whereas higher 
levels disrupt homeostasis, is known as hormesis [209, 
210]. Thus, dependent on its intracellular level, ROS 
can have both pathogenic, aging accelerating as well as 
lifespan increasing actions [208, 211, 212]. 
 
Effect of H2S on mitochondria 
The effects of H2S on mitochondria are well described 
and its ability to reduce and modulate oxidative stress is 
considered to be one of the principal features of H2S in 
physiology. Several studies showed protective effects of 
H2S on mitochondrial function, as it increased the levels 
of antioxidants [213, 214], reduced the production of 
mitochondrial superoxides [215] and activated ROS-
scavengers [216] and the anti-oxidative transcription 
factor Nrf2 [217, 218]. NaHS treatment stimulates the 
activities of superoxide dismutase and glutathione 
peroxidase and upregulated the expression of other 
antioxidants in human neuroblastoma cell line SH-
SY5Y [143]. H2S improves mitochondrial ATP 
production in smooth muscle cells with impaired ATP 
production, especially following hypoxia [38]. Under 
stress conditions, cells can use H2S as an inorganic 
energy substrate for the mitochondrial respiratory chain 
to sustain ATP production [219-221]. It was proposed 
that high concentrations of H2S inhibit mitochondrial 
activity and protected organs against 
ischemia/reperfusion injury by reversible binding to 
cytochrome c oxidase, leading to hypometabolism, 
hypothermia and tissue preservation [79, 222-224]. 
 
As discussed previously, H2S protects the mitochondrial 
genome from damage and thereby preserves the 
mitochondrial integrity and the cellular energetics [38, 
89, 125, 222]. Together these actions induced by H2S 
protect the integrity of mitochondria and prevent 
mitochondrial dysfunction. 
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Cellular senescence 
The cell-cycle of damaged cells can be arrested and 
cells become senescent in order to prevent unrestricted 
growth [225, 226]. Senescent cells undergo 
characteristic phenotypic alterations, including 
activation of tumor-suppressors, epigenetic changes and 
changes to their secretome [15, 226, 227]. Cellular 
senescence was suggested to be a beneficial 
compensatory response to eliminate damaged, 
potentially oncogenic cells from tissues in order to 
replace them to re-establish cell numbers [15]. 
Experimental studies support this principle where a 
mild enhancement of the senescence pathways extended 
longevity in mice [228, 229] and elimination of the 
involved pathways was beneficial for mice with 
premature aging diseases [70, 230, 231]. 
 
Telomere attrition [232], DNA lesions [233], oxidative 
stress [234] and activated oncogenes [235, 236] are 
examples of stressors shown to induce senescence by 
the activation of the DNA damage response, which 
arrests cell-cycle through stabilization of p53 and 
transcriptional activation of p21 [226]. Other pathways, 
such as the p16INK4a/Rb and the p19ARF/p53 pathways, 
can also induce senescence, independent of the DNA 
damage response [226, 237]. These pathways were 
genetically linked to the highest number of age-related 
diseases [238] and correlated with the chronological age 
of essentially all tissues analyzed in both mice and 
humans [239, 240]. Other studies underscored the close 
relationship between metabolic changes and senescence 
[235, 241-243]. 
 
The altered secretome of senescent cells, with enhanced 
amounts of pro-inflammatory cytokines and 
chemokines, normally stimulates the innate immune 
system to eliminate senescent cells but may also 
contribute to or even accelerate the aging process when 
the turnover system becomes inefficient [15, 226, 227, 
244]. The accumulation of senescent cells was shown in 
some, but not all, tissues with age demonstrating that 
this process became inefficient [15, 245]. During cell-
cycle arrest, senescence can also be prevented by a 
process called assisted cycling, in which the cellular 
disabilities are mended [226, 246]. 
 
Effect of H2S on cellular senescence 
Several lines of evidence indicate the involvement of 
H2S in cellular and organismal senescence. NaHS 
protects human umbilical vein endothelial cells against 
cellular senescence, potentially through the modulation 
of SIRT1 activity, and improves the function of 
senescent cells [119, 121]. Cellular aging can be 
delayed by decreasing oxidative stress. H2S protects 
against stress-induced cellular senescence by initiating 
the antioxidant responses, for example by S-
sulfhydration of Keap1 leading to the activation of Nrf2 
[218] and by inhibition of mitochondrial ROS 
production, by S-sulfhydration of p66Shc which 
prevents its phosphorylation and activation [247]. 
Others demonstrated that H2S induced the S-
sulfhydration of MEK1, leading to PARP-1 activation 
and DNA damage repair, protecting cells from 
senescence [86]. Caloric restriction, reported to 
decelerate the biological aging process, maintained 
normal H2S levels, reduced oxidative stress-induced 
cellular senescence and promoted cellular cyto-
protective systems [248]. In addition, deficiency of CSE 
in mouse embryonic fibroblasts led to early 
development of cellular senescence [218], under-
scoring the regulative role of H2S signaling in 
senescence. 
 
Role of H2S in the integrative hallmarks of aging 
 
Stem cell exhaustion 
Stem cells regularly replace damaged or missing cells in 
tissues in order to maintain tissue homeostasis [249]. 
Most stem cells remain in their quiescent state and 
rarely enter cell-cycle in order to prevent the 
accumulation of damage during normal metabolic 
respiration and cell division [250]. However, not all 
damage can be prevented, resulting in a decline in stem 
cell function with age. As a consequence, their 
regenerative potential may be adversely affected, 
leading to organ failure and diseases of aging [250]. The 
previously discussed hallmarks are involved in the 
decline of stem cell function with age, as for example 
the accumulation of DNA damage [251] and telomere 
shortening [252, 253] were shown to attribute to stem 
cell exhaustion. In addition, stem cells are extremely 
sensitive to the loss of telomerase, which they normally 
express in order to maintain their genomic integrity 
[254, 255]. Stem cell attrition is thought not to be a 
direct result of the DNA damage itself but to be a 
product of the cellular responses to the damage, such as 
the activation of p53 that initiate DNA repair 
mechanisms and cell death programs [256, 257]. 
Studies also showed that stem cell function could be 
improved after calorie restriction [258, 259] or mTOR 
inhibition [259-261] in several tissues, resulting in 
improved proteostasis and affecting the energy sensing 
networks. A study in hematopoietic stem cells showed 
that epigenetic dysregulation during aging declined the 
regenerative potential and function of stem cells [262]. 
Besides the need to prevent functional decline of stem 
cells, organisms need to prevent the excessive 
proliferation of stem cells which could result in 
exhaustion of the stem cell compartment and accelerate 
aging [15]. Several physiological alterations observed 
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during aging are thought to reflect an attempt of the 
organism to preserve the quiescence of stem cells [15]. 
 
Effect of H2S on stem cell maintenance 
Several stem cell populations are affected by H2S. 
Endogenous H2S signaling maintains several biological 
functions of human periodontal ligament stem cells and 
neural stem cells, like the capacity to proliferate and 
differentiate [263-265]. Exogenous H2S may protect 
against neuronal decline normally observed after 
hypoxia [265]. In addition, NaHS increased and CSE 
inhibition decreased proliferation of human adipose 
tissue derived stem cells [266]. Bone marrow 
mesenchymal stem cells produce H2S in order to 
regulate their self-renewal and differentiation capacity 
[267]. Deficiencies in H2S signaling impaired stem cell 
function and bone homeostasis, which could be restored 
by H2S application [267]. Mesenchymal stem cells 
exposed to hypoxic conditions significantly decreased 
their H2S production and underwent apoptosis, whereas 
CSE overexpression protected against apoptosis [268]. 
Modulation of H2S signaling was suggested to be a 
potential therapeutic approach by which the viability of 
transplanted stem cells and the efficiency of cell-based 
therapy could be promoted [266, 268, 269]. 
 
Interestingly, the dedifferentiation of several cancer 
cells, a process in which cancer cells regain 
characteristics of undifferentiated stem cells, was 
characterized by the accumulation of H2S and the 
upregulation of H2S producing enzymes [270]. 
Reducing the H2S production in these cells reversed 
their ability to dedifferentiate, whereas the 
accumulation of H2S induced their dedifferentiation 
[270]. Altogether, these studies show that stem cell 
maintenance and H2S signaling are connected. 
 
Altered intercellular communication 
Whereas the previously discussed hallmarks of aging 
mainly focused on age-associated intracellular 
alterations, the interaction between cells also changes 
with age. As a result of aging, the extracellular 
environment of cells may change, altering their 
intercellular communication [15]. The changed 
secretome of senescent cells is an example of such an 
alteration in the paracrine interaction between cells [15, 
226, 227, 244]. Senescent cells were also described to 
induce senescence in neighboring cells via juxtacrine 
signaling and processes involving ROS [271]. 
Alterations on several other levels of intercellular 
communication, like endocrine, neuroendocrine or 
neuronal signaling [150, 272-274], during aging have 
been described [15]. The age-associated alterations in 
the insulin/IGF-1 network are examples of how the 
neuroendocrine communication can be altered with age. 
Another important example of altered intercellular 
communication is ‘inflammaging’, in which mammalian 
aging is accompanied by a pro-inflammatory phenotype 
[275]. Some age-related pathologies, like obesity, type 2 
diabetes [152] and atherosclerosis [276], were 
associated with inflammation. Numerous age-associated 
alterations, such as the pro-inflammatory secretome of 
senescent cells, the activation of NF-κB signaling and a 
failing autophagy response during aging, contribute to 
inflammaging [196, 275]. The function of the adaptive 
immune system declines with age due to immuno-
senescence leading to impaired clearance of infectious 
agents and infected, damaged or senescent cells, which 
may, in turn, aggravate the aging phenotype [15, 277]. 
Sirtuins may also contribute to this phenotype by 
changing the expression of inflammatory genes [278]. 
 
The age-associated alterations in intercellular 
communication also explain the interorgan coordination 
of aging, in which lifespan-extending manipulations in 
one tissue were described to retard the aging process in 
other tissues [279-282]. Manipulation of the gut 
microbiome was also suggested to retard aging as it 
may affect the efficiency and function of the host 
immune system and exert systemic metabolic effects 
[15, 283, 284]. 
 
Effect of H2S on intercellular communication 
Several studies showed that H2S treatment alters 
intercellular communication. Hydrogen sulfide was 
proposed to mediate inflammation, however both pro- 
and anti-inflammatory actions are described [8]. At low, 
physiological concentrations, H2S is predominantly 
anti-inflammatory, whereas high H2S concentrations 
may promote inflammation [28, 285]. Pro-inflammatory 
cytokines increase endogenous H2S production in 
chondrocytes and mesenchymal progenitor cells [286], 
whereas L-cysteine or NaHS administration decreased 
NF-κB phosphorylation and reduced the secretion of 
pro-inflammatory cytokines in human U937 monocytes 
treated with high-glucose [181]. Exogenous H2S 
protects H9c2 cardiac cells against high glucose-
induced inflammation and injury by inhibiting the NF-
κB/IL-1β pathway [287]. Consistently, NaHS decreased 
the secretion of pro-inflammatory cytokines in mice 
with severe hepatic ischemia and reperfusion injury, via 
mechanisms involving Nrf2 [288]. Neuroinflammation 
and vascular inflammation were modulated by H2S, in 
part through the activation of AMPK and the reduction 
of oxidative stress by H2S [181, 183]. Beside the effects 
of H2S on inflammation, H2S depresses gap junction 
intercellular communication, which inhibited human 
platelet aggregation in vitro [289]. Diffusion of H2S 
from an H2S-producing cell into neighboring cells 
affects ion management and intracellular processes [8, 
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146, 290]. H2S regulates various ion channels and 
transporters by sulfhydrating specific cysteine residues 
of  subunits  of  these  protein  complexes  [8, 146, 290].  
Several calcium and potassium channels associated with 
biological processes, such as cardiac contraction, 
sensory transduction, inflammation and neuro-
protection, were shown to be manipulated by H2S [8, 
146, 290]. These effects of H2S have also been observed 
in the cerebral microcirculation in response to hypoxia, 
where H2S produced in astrocytes causes vasodilatation 
by diffusion into the contractile pericytes that surround 
the arterioles [291]. Impaired H2S production might 
thus result in vascular dysfunction and other 
pathophysiologies [8, 146]. Taken together, these 
studies demonstrate that H2S may have anti-aging 




The precise relationship between H2S and aging still 
remains unknown. However, the findings discussed in 
this review strongly support the idea that H2S plays a 
role in the process of aging and in age-related 
pathologies, as direct effects on pathways related to 
aging were shown in all but one hallmarks of aging 






























are important in the light of aging, but together they 
indicate that the contribution of H2S signaling to normal 
physiology and to pathophysiology is not to be neglected. 
 
Treatment with H2S or influencing the transsulfuration 
pathways may become an intervention to prevent, delay 
or reverse aging and accompanying symptoms and 
pathologies. However, both beneficial as well as 
detrimental effects of H2S application were shown in 
several hallmarks, indicating that administration of H2S 
dictates great caution. The underlying pathways of both 
the aging process and the (patho-) physiological 
processes of H2S signaling need to be studied more 
extensively. Combining these studies may shed new 
lights on the role of H2S in aging is needed in order to 
determine the possible preventive and therapeutic 
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Figure 3. Overview of  the effects of physiological  levels of H2S on  the Hallmarks of Aging. Hydrogen  sulfide
affects  at  least  one  pathway  involved  in  almost  all  hallmarks  of  aging.  A  direct  effect  of H2S  on  pathways  involved  in
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